Literature DB >> 15335551

Medico-legal aspects of doping.

B Madea1, W Grellner, F Musshoff, R Dettmeyer.   

Abstract

Abuse of anabolic steroids is an increasing problem not only among athletes but also body-builders and teenagers. A fast-developing black market has been established since the opening of the borders to eastern Europe. Medico-legal aspects of doping are addressed with particular reference to toxicology and pathology. Constituents of anabolic steroids bought on the black market were identified using gas chromatography/mass spectrometry; the products did not contain the expected ingredients in 35% of cases. Long-term effects and fatalities because of anabolic steroid abuse are reported here based on our own case material and a literature review. In our own cases, severe cardiovascular side-effects developed after long-term abuse of Dianabol (methandrostenolone) and Oral-Turinabol (chlordehydromethyltestosterone), i.e. myocardial infarction, stroke, organomegaly and/or severe atherosclerosis. The pathogenesis of cardiovascular complications (cardiotoxic effect, risk of atherosclerosis, thrombogenic risk) is discussed based on the available literature reports following fatal outcome after the abuse of anabolic steroids.

Entities:  

Year:  1998        PMID: 15335551     DOI: 10.1016/s1353-1131(98)90001-3

Source DB:  PubMed          Journal:  J Clin Forensic Med        ISSN: 1353-1131


  2 in total

1.  Myocardial performance and aortic elastic properties in elite basketball and soccer players: relationship with aerobic and anaerobic capacity.

Authors:  Bedrettin Akova; Dilek Yesilbursa; Ufuk Sekir; Hakan Gür; Akin Serdar
Journal:  J Sports Sci Med       Date:  2005-06-01       Impact factor: 2.988

2.  Ventricular androgenic-anabolic steroid-related remodeling: an immunohistochemical study.

Authors:  Rossana Cecchi; Barbara Muciaccia; Costantino Ciallella; Natale Mario Di Luca; Akihiko Kimura; Cristina Sestili; Mizuho Nosaka; Toshikazu Kondo
Journal:  Int J Legal Med       Date:  2017-04-21       Impact factor: 2.686

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.